Phosphatidylserine on microparticles and associated cells contributes to the hypercoagulable state in diabetic kidney disease

Abstract

Our results suggest that PS+ MPs and MP-origin cells play procoagulant roles in patients with DKD. Blockade of PS could become a novel therapeutic modality for the prevention of thrombosis in these patients.